Ypsomed signs long-term supply agreement with Novo Nordisk for autoinjectors

Ypsomed concluded a long-term supply agreement with Novo Nordisk for large quantities of YpsoMate 1ml autoinjectors for metabolic disease self-treatment. Novo Nordisk will contribute a significant part of the investment for new production infrastructure, with first capacity available in 2025.

“The conclusion of this contract marks an important milestone for Ypsomed.”ypsomed.com

• 1 source
• ypsomed.comYpsomed concludes a long-term supply agreement for large quantities of autoinjectors - YpsomedSep 20, 2023

Summarized from public sources; check the original articles before acting on it.